Updated:
Novogenia
Novogenia is a other based in Eugendorf, founded 2009; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts for...
Novogenia
Become a partner of Novogenia and offer your customers innovative genetic analyses for health, prevention and well-being
General information
Firm type
other
Year founded
2009
Location
Region
North America
Country
Austria
City
Eugendorf
Corporate office
Strass 19, 5301 Eugendorf, Austria
Principals
Dr. Daniel Wallerstorfer
Founder & Chief Executive Officer
Michael Huttegger
Chief Operating Officer
Matthias Probst
Chief Financial Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Novogenia?
Novogenia is an operating company, not an investment vehicle. Dr. Daniel Wallerstorfer, founder and CEO, directs the firm's scientific and product strategy. Financial oversight falls to Matthias Probst, who also serves as CFO of related Darwin Group entities.
Is Novogenia a single family office?
No. Novogenia is a biotechnology firm that provides genetic testing and related products. It does not manage capital for a family or pool external LP commitments. It operates as a for-profit business subsidiary of Darwin AG.
How does Novogenia generate revenue?
The firm sells genetic test kits — ShapePlus, LifestylePlus, PerformancePlus — to health and nutrition professionals, fitness trainers, and medical practitioners. These partners then offer the tests to their own clients. Novogenia does not sell directly to consumers.
Does Novogenia have any connection to a wealthy family?
No. The firm is part of Darwin AG, a publicly traded biotechnology holding company that listed on the Munich Stock Exchange in 2019. No single family controls the firm as a family office.
What geographic markets does Novogenia serve?
Novogenia is based in Austria and states on its website that it aims to become the leading provider of personalized products in Europe first, then worldwide. Its partner network appears concentrated in German-speaking Europe.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: